Alethiomics
Headington
About Alethiomics
Alethiomics is a pre-clinical biotech company harnessing the power of single-cell multi-omic technology to discover and develop life-changing treatments for patients with blood cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $8.0M
- Funding stage: Seed
- Last round: Seed (Dec 2021)
- Website: alethiomics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/alethiomics-144712 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.